Increased interstage morbidity and mortality following stage 1 palliation in patients with genetic abnormalities.

Alyson R PierickTrudy A PierickThomas D ScholzM Bridget ZimmermanBenjamin E Reinking

Published in: Cardiology in the young (2022)

Patients with genetic abnormalities experienced greater morbidity and mortality during the interstage period than those with no reported genetic abnormalities. Genetic testing and reporting practices vary significantly between participating centres.

Keyphrases

genome wide
copy number
healthcare
primary care
gene expression
dna methylation